Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Effect of dicloxacillin sodium on the hypoprothrombinemic response to warfarin sodium.

Krstenansky PM, Jones WN, Garewal HS.

Clin Pharm. 1987 Oct;6(10):804-6. No abstract available.

PMID:
3505843
2.
3.

Lack of effect of fluoxetine on the hypoprothrombinemic response of warfarin.

Ford MA, Anderson ML, Rindone JP, Jaskar DW.

J Clin Psychopharmacol. 1997 Apr;17(2):110-2.

PMID:
10950474
4.

Influence of mitotane on the hypoprothrombinemic effect of warfarin.

Cuddy PG, Loftus LS.

South Med J. 1986 Mar;79(3):387-8.

PMID:
3952554
5.

Enhanced hypoprothrombinemia with warfarin due to azithromycin.

Rao KB, Pallaki M, Tolbert SR, Hornick TR.

Ann Pharmacother. 2004 Jun;38(6):982-5. Epub 2004 Apr 14.

PMID:
15084685
6.

Phenylbutazone and sulfinpyrazone interaction with oral anticoagulant phenprocoumon.

O'Reilly RA.

Arch Intern Med. 1982 Sep;142(9):1634-7.

PMID:
7114982
7.

Cimetidine potentiation of the hypoprothrombinemic effect of warfarin.

Silver BA, Bell WR.

Ann Intern Med. 1979 Mar;90(3):348-9. No abstract available.

PMID:
426403
8.

Quinidine-induced hypoprothrombinemic hemorrhage in patients on chronic warfarin therapy.

Koch-Weser J.

Ann Intern Med. 1968 Mar;68(3):511-7. No abstract available.

PMID:
5643674
9.

The rabbit as an animal model for warfarin-induced hypoprothrombinemia: the relationship between prothrombin time and prothrombin complex activity.

Nagata M, Yotsuyanagi T, Ikeda K.

Chem Pharm Bull (Tokyo). 1986 Feb;34(2):813-8. No abstract available.

PMID:
3708732
10.

Low-dose fluconazole therapy potentiates the hypoprothrombinemic response of warfarin sodium.

Crussell-Porter LL, Rindone JP, Ford MA, Jaskar DW.

Arch Intern Med. 1993 Jan 11;153(1):102-4.

PMID:
8422191
11.

Enhancement of warfarin-induced hypoprothrombinemia by thyrotoxicosis.

Vagenakis AG, Cote R, Miller ME, Braverman LE, Stohlman F Jr.

Johns Hopkins Med J. 1972 Jul;131(1):69-73. No abstract available.

PMID:
4114451
12.

Enhancement of warfarin-induced hypoprothrombinemia by triclofos.

Sellers EM, Lang M, Koch-Weser J, Colman RW.

Clin Pharmacol Ther. 1972 Nov-Dec;13(6):911-5. No abstract available.

PMID:
5081604
13.

Prothrombin complex concentrates in acquired hypoprothrombinemia.

Sandler SG, Rath CE, Ruder A.

Ann Intern Med. 1973 Oct;79(4):485-91. No abstract available.

PMID:
4748270
14.

Ciprofloxacin-warfarin coagulopathy: a case series.

Ellis RJ, Mayo MS, Bodensteiner DM.

Am J Hematol. 2000 Jan;63(1):28-31.

PMID:
10602164
15.

Continuation of warfarin-nafcillin interaction during dicloxacillin therapy.

Taylor AT, Pritchard DC, Goldstein AO, Fletcher JL Jr.

J Fam Pract. 1994 Aug;39(2):182-5. Review.

PMID:
8057070
16.

Warfarin-induced hypoprothrombinemia. Potentiation by hyperthyroidism.

Self T, Weisburst M, Wooten E, Straughn A, Oliver J.

JAMA. 1975 Mar 17;231(11):1165-6. No abstract available.

PMID:
1172818
17.

Lovastatin. Warfarin interaction.

Ahmad S.

Arch Intern Med. 1990 Nov;150(11):2407.

PMID:
2241455
18.

Warfarin-associated hypoprothrombinemia: an unusual presentation.

Williams D, Ponte CD.

Am J Health Syst Pharm. 2003 Feb 1;60(3):274-8. Review. No abstract available.

PMID:
12613238
19.

Potential interaction between warfarin and dicloxacillin.

Mailloux AT, Gidal BE, Sorkness CA.

Ann Pharmacother. 1996 Dec;30(12):1402-7.

PMID:
8968452
20.

Interaction of dicloxacillin with warfarin.

Lacey CS.

Ann Pharmacother. 2004 May;38(5):898. Epub 2004 Mar 30. No abstract available.

PMID:
15054148

Supplemental Content

Support Center